Skip to main content
Scientists test novel organ acceptance therapy in mice

A nanotechnology-based immunotherapy, developed by researchers from the Icahn School of Medicine at Mount Sinai and tested in mice, is intended to inhibit organ rejection in transplant recipients without the side effects that typically result from traditional immunosuppressant drugs. Details of the research were published in Immunity.

Full Story: